Recent advances in optimizing radiation therapy decisions in early invasive breast cancer

N Riaz, T Jeen, TJ Whelan, TO Nielsen - Cancers, 2023 - mdpi.com
Simple Summary Radiation therapy is routinely prescribed for women who undergo breast-
sparing surgery for early breast cancers. Over the years, advancements in diagnosis and …

Breast Cancer Circulating Tumor Cells: Current Clinical Applications and Future Prospects

AK Cani, DF Hayes - Clinical Chemistry, 2024 - academic.oup.com
Background Identification and characterization of circulating tumor markers, designated as
“liquid biopsies,” have greatly impacted the care of cancer patients. Although more recently …

Circulating tumor cells in early breast cancer

L Thery, A Meddis, L Cabel, C Proudhon… - JNCI cancer …, 2019 - academic.oup.com
Circulating tumor cells (CTCs) are particularly rare in non-metastatic breast cancer, and the
clinical validity of CTC detection in that clinical setting was initially not well recognized. A …

Cardiotoxicity in breast cancer patients treated with radiation therapy: From evidences to controversies

P Loap, K Kirov, Y Kirova - Critical Reviews in Oncology/Hematology, 2020 - Elsevier
Radiation therapy has a prime importance for breast cancer management. However, first-
generation techniques delivered significant radiation dose to the heart, which substantially …

Dynamics of circulating tumor DNA during postoperative radiotherapy in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: a …

H Kim, YJ Kim, D Park, WY Park, DH Choi… - Breast Cancer Research …, 2021 - Springer
Background This study was performed to evaluate circulating tumor DNA (ctDNA) kinetics
during postoperative radiotherapy (PORT) in patients with residual triple-negative breast …

Which target volume should be considered when irradiating the regional nodes in breast cancer? Results of a network-meta-analysis

J Haussmann, W Budach, B Tamaskovics, E Bölke… - Radiation …, 2019 - Springer
Purpose/objective (s) Radiation treatment to the regional nodes results in an improvement in
survival in breast cancer according to a meta-analysis of randomized trials. However …

The role of circulating tumor cells in breast cancer and implications for radiation treatment decisions

CR Goodman, CW Speers - International Journal of Radiation Oncology …, 2021 - Elsevier
Tumor biomarkers are used routinely in oncology to assign risk categorization, screen and
assist in diagnosis of malignancy, allow for prognostication and prediction of outcomes and …

[HTML][HTML] Radiation Therapy for Early-Stage Breast Cancer

CS Kim, O Algan - 2017 - europepmc.org
Objectives: Describe the population in which breast cancer typically occurs. Summarize
physical exam findings that should prompt further evaluation for breast cancer. Describe the …

Customising radiotherapy in stage II breast cancer after primary chemotherapy

Y Kirova, P Loap - The Lancet Oncology, 2022 - thelancet.com
Neoadjuvant chemotherapy for breast cancer management is increasingly used in clinical
practice for large or locoregionally advanced tumours. Tumour response after neo adjuvant …

[HTML][HTML] Circulating erythroblast abnormality associated with systemic pathologies may indicate bone marrow damage

S Schreier, P Budchart, S Borwornpinyo… - Journal of Circulating …, 2021 - ncbi.nlm.nih.gov
Background: The circulating rare cell population is diverse and rich in diagnostic
information. Its characterization and clinical exploitation by cell-based liquid biopsy is an …